EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:
• Compare criteria for choosing onabotulinumtoxinA
or neuromodulation treatment for individual patients
with refractory OAB
• Perform procedural techniques for use of
intradetrusor injections of onabotulinumtoxinA
and office-based neuromodulation for
refractory OAB
|
|
PHYSICIAN ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MedEdicus LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.
PHYSICIAN CREDIT DESIGNATION
Global Education Group designates this CME activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
|
